Key points are not available for this paper at this time.
This is the largest study to examine the association between T2DM and prostate cancer accounting for tumor risk group and diabetes treatment.
Fall et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: